Home » Acucela, Strengthening Ties With Otsuka, Gets Right to Develop New Drug
Acucela, Strengthening Ties With Otsuka, Gets Right to Develop New Drug
Little biotech companies usually discover new drugs, and hand them off for development to a Big Pharma company with cash and expertise in running clinical trials. But one of the Seattle area’s little biotech companies, Acucela, is doing the exact opposite, and doing it in a profitable way.
Xconomy
Xconomy
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May